Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
20,93 USD | +4,23% |
|
+1,95% | -3,15% |
Attività
Numero di dipendenti: 184
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05/05/15 |
Peter Ordentlich
FOU | Founder | 55 | 11/10/05 |
Neil Gallagher
PSD | President | 60 | 10/04/23 |
Keith Goldan
DFI | Director of Finance/CFO | 52 | 13/06/22 |
Chief Tech/Sci/R&D Officer | 52 | - | |
Sharon P. Klahre
IRC | Investor Relations Contact | - | 13/06/22 |
Anjali Ganguli
PRN | Corporate Officer/Principal | 48 | 01/05/15 |
Kevin McManus
HRO | Human Resources Officer | - | 01/05/23 |
Luke Albrecht
LAW | General Counsel | 45 | 01/08/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29/03/17 |
Dennis Podlesak
CHM | Chairman | 66 | 01/12/08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04/01/17 |
William Meury
BRD | Director/Board Member | 56 | 25/09/18 |
Martin Huber
BRD | Director/Board Member | 64 | 15/09/21 |
Michael Metzger
CEO | Chief Executive Officer | 53 | 05/05/15 |
Jennifer Jarrett
BRD | Director/Board Member | 53 | 25/09/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 84 987 060 | 83 417 153 ( 98,15 %) | 0 | 98,15 % |
Coordinate società
Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive Building D
02451, Waltham
+781 419 1400
http://www.syndax.com![Indirizzo Syndax Pharmaceuticals, Inc.(SNDX)](https://cdn.zonebourse.com/static/address/16725742.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-3,15% | 1,78 Mrd | |
+18,97% | 45,34 Mrd | |
+41,98% | 40,42 Mrd | |
-10,06% | 37,92 Mrd | |
+31,15% | 31,75 Mrd | |
-7,79% | 27,71 Mrd | |
+13,32% | 26,52 Mrd | |
+43,05% | 13,96 Mrd | |
+31,28% | 12,44 Mrd | |
-7,41% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione SNDX
- Società Syndax Pharmaceuticals, Inc.